CLOSE X
RK Global
MISSED CALL NO
7412074708
MISSED CALL NO
7412074708
Signup
About
Pricing
Login
Client Dashboard
Online Trading
Back Office
DP Backoffice
Delhi
Kolkata
Webmail
Online IPO
Due Diligence Report
Client Collateral Details
Support
Reactivation
Account Modification
Segment Modification
Nominee Modification
Remote Help
Contact us
Search
Company Profile
Equity
Derivatives
IPO
Mutual Fund
Currency
Commodity
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Markets
Company Profile
Financial Ratios
Financial Ratios
PROCTER & GAMBLE HEALTH LTD.
NSE :
PGHL
BSE :
500126
ISIN CODE :
INE199A01012
Industry :
Pharmaceuticals & Drugs
House :
Merck - MNC
BSE
4810.15
39.55 (+0.83 %)
PREV CLOSE (
)
4770.60
OPEN PRICE (
)
4765.00
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
2522
TODAY'S LOW / HIGH (
)
4699.70
4895.00
52 WK LOW / HIGH (
)
4725.05
6700
NSE
4810.70
32.1 (+0.67 %)
PREV CLOSE(
)
4778.60
OPEN PRICE (
)
4778.60
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
4810.70 (3)
VOLUME
36553
TODAY'S LOW / HIGH(
)
4707.00
4903.30
52 WK LOW / HIGH (
)
4725
6739
Consolidated
Standalone
Select year
Mar2025
Jun2024
Jun2023
Jun2022
Jun2021
Particulars
Mar 2025
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Operational & Financial Ratios
Earnings Per Share (Rs)
141.21
121.07
138.23
115.98
106.51
CEPS(Rs)
151.27
137.58
155.16
132.29
124.60
DPS(Rs)
125.00
260.00
95.00
52.50
130.00
Book NAV/Share(Rs)
320.52
319.10
447.62
366.99
421.59
Tax Rate(%)
24.78
26.47
26.97
24.02
24.21
Margin Ratios
Core EBITDA Margin(%)
30.94
24.30
24.44
22.73
24.39
EBIT Margin(%)
30.32
21.76
23.71
21.55
23.21
Pre Tax Margin(%)
30.28
21.71
23.66
21.51
23.13
PAT Margin (%)
22.78
15.96
17.28
16.35
17.53
Cash Profit Margin (%)
24.40
18.14
19.39
18.64
20.50
Performance Ratios
ROA(%)
30.85
13.43
11.00
9.83
8.65
ROE(%)
44.15
31.58
33.94
29.41
22.04
ROCE(%)
58.05
42.52
46.07
38.45
29.08
Asset Turnover(x)
1.35
0.84
0.64
0.60
0.49
Sales/Fixed Asset(x)
4.62
5.18
5.27
5.17
4.87
Working Capital/Sales(x)
3.31
4.12
2.70
3.13
2.07
Efficiency Ratios
Fixed Capital/Sales(x)
0.22
0.19
0.19
0.19
0.21
Receivable days
40.92
29.14
27.36
22.20
28.06
Inventory Days
38.75
35.37
34.37
36.19
45.68
Payable days
235.41
223.07
206.35
188.51
177.09
Valuation Parameters
PER(x)
36.42
41.71
37.97
36.10
52.52
PCE(x)
34.00
36.71
33.83
31.65
44.89
Price/Book(x)
16.04
15.83
11.73
11.41
13.27
Yield(%)
2.43
5.15
1.81
1.25
2.32
EV/Net Sales(x)
8.94
7.07
6.73
5.95
8.74
EV/Core EBITDA(x)
25.39
25.30
24.12
23.59
33.38
EV/EBIT(x)
26.75
29.70
26.27
26.11
37.67
EV/CE(x)
15.55
15.12
11.02
3.42
4.46
M Cap / Sales
9.14
7.28
7.09
6.24
9.21
Growth Ratio
Net Sales Growth(%)
-18.86
-6.37
10.34
10.48
-25.60
Core EBITDA Growth(%)
2.21
-6.25
22.15
6.34
-31.27
EBIT Growth(%)
13.87
-12.99
24.11
8.42
-34.03
PAT Growth(%)
16.63
-12.42
19.19
8.89
-30.42
EPS Growth(%)
16.63
-12.42
19.19
8.89
-30.42
Financial Stability Ratios
Total Debt/Equity(x)
0.00
0.00
0.00
0.00
0.00
Current Ratio(x)
2.44
2.39
1.72
1.62
1.89
Quick Ratio(x)
1.94
1.90
1.53
1.43
1.67
Interest Cover(x)
725.70
380.61
409.05
604.26
292.60
Total Debt/Mcap(x)
0.00
0.00
0.00
0.00
0.00